companiesCompany
WuXi XDC
WuXi XDC is the largest dedicated ADC CDMO, spun out of WuXi Biologics and listed in Hong Kong in 2023; it is exposed to US BIOSECURE Act politics.
Integrated antibody, payload-linker, conjugation, and fill-finish services; a large share of the world's clinical ADCs are made here; building a Singapore site to diversify from China.